StockWatch
·
OLA ELECTRIC MOBILITY LTD · QQ2 FY-2027 · THE CALL

Demand claims ring hollow amid 39% YoY revenue collapse, margin guidance cut to 30%

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsOLAELECOla Electric Mobility Ltd17 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade C

Prior FY26 guidance (35-40% GM, ₹250-300 Cr quarterly OpEx) partially missed. Q2 delivered 30% GM, OpEx still above target.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Management narrative of demand-led growth and cost reset is contradicted by -39% YoY revenue collapse and operating margin deterioration despite OpEx stabilization. Dealer transition and cell integration are real catalysts, but margin guidance was cut (35-40% → 30%), execution timelines are vague (cell yields, S1Z launch), and the company is 18+ months from operating profitability.

₹420 Cr

Revenue · −39.1% YoY

₹-362 Cr

Reported PAT · +13.4% YoY

Compressing

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

Demand ahead of supply, can sell every vehicle produced

OVERSTATED

Revenue ₹420 Cr, down 39% YoY; volumes 35-36K units (constrained by chargers, not demand)

OpEx stabilized, gross margin held at 30% mark

MISS

OpEx ₹369 Cr vs ₹390 Cr adj Q1 (down), but still above ₹250-300 Cr target. GM 30% vs 35-40% prior guidance

Operating EBITDA improving and meaningful cash flow improvement

MISS

Operating EBITDA -₹246 Cr (Q2) vs -₹195 Cr (Q1), worsened despite lower OpEx

Dealer transition very encouraging, 300+ stores in 2 months

MET

255 dealers live by Nov 8; targeting 450 by Dec, 700+ by Mar 2027. Real progress but margin-dilutive

Cell facility COD achieved, 6 GWh commissioned on schedule

MET

Achieved COD 23 Sept, added 3.5 GWh to 2.5 GWh existing, total 6 GWh. Government extended PLI to 2031

NMC yields mid-70s, targeting mid-80s next couple months

Partial

Mid-70s yields claimed. No timeline given for mid-80s or roadmap to 90%; vague itemization promised

Earnings quality

What changed since the last call

Deltas vs. the prior call

Gross margin guidance cut

Downgrade

FY27 guidance was 35-40%; delivered 30% in Q2, further pressure in Q3-Q4 from dealer commissions

EBITDA trajectory reversed

Downgrade

Operating EBITDA -₹246 Cr (Q2) vs -₹195 Cr (Q1); deteriorated despite management claims of stabilization

Cell expansion roadmap extended

Neutral

Stabilize 6 GWh first (next couple quarters), then expand to 20 GWh mid-to-long term (timeline vague)

Dealer transition accelerated, margins penalty acknowledged

Neutral

255 stores live, targeting 700+ by Mar 2027; management concedes GM decline Q3-Q4 but promised OM recovery

The Q&A

Analysts pressed hard on margin degradation, BoM gap vs competitors, and cell yield timelines. Management defended vertical integration story and cost structure reset, but was evasive on equity raised and S1Z launch timing (shifted language to 'might' delays).

The exchanges that mattered

Volume detail — Arvind Sharma, Citi

Answered

35,000-36,000 units booked. 4,000-5,000 couldn't be booked due to charger constraints; would have been 40,000-41,000.

Gross margin decline — Arvind Sharma, Citi

Partial

Largely commodities, slightly higher than before. Raised prices to nullify some. GM will decline Q3-Q4 due to dealer commissions, but OM improves from Q3 onwards.

FY28 cell roadmap — Chintan Jain, Sagun Capital

Answered

Average 5 kWh per vehicle for FY28 (currently 3.8 kWh). At 2-3 GWh, that's 400-500K orders/units for FY28.

BoM competitiveness — Akshay Satija, Alpha Invesco

Partial

Our BoM is slightly higher than ₹80K but 15-20% lower overall. Vertical integration and technology. Will come down further via LFP and Gen 4 platform (Q4).

Cell yields timeline — Akshay Satija, Alpha Invesco

Partial

We are at mid-70s NMC yields currently, targeting mid-80s next couple months. Clear itemized roadmap to 90%, not hocus-pocus. We've been at this 6 years since 2020.

GST refund recovery — Akshay Satija, Alpha Invesco

Answered

₹1,000 Cr outstanding (30-40% future inverted-duty structure). 90% auto-approval; timeline cuts from 3-4 months to 1-2 months. Meaningful cash flow benefit, partly government policy, partly D2C→dealer transition.

Equity raised — Siddhant Dand, Goodwill

Dodged

Pre-IPO ₹2,500 Cr. IPO ₹5,000 Cr. QIP and rights last week — doesn't want to hazard a guess, says ₹2,500 might be off.

S1Z launch timeline — Purveshchandra Patel, Acacia Capital

Partial

Will be in Q4. Testing underway, so we will take a call when to put it out. Only ₹500-1000 Cr reservations. Focus on scaling supply chain to meet demand, not accelerating S1Z.

In-house cell cost advantage — Purveshchandra Patel, Acacia Capital

Partial

Meaningful cost advantage using own cells. Assume ~20% cost advantage at right scale of production. 46160 LFP cells per 1 kWh is lower than 4680 count.

Cell capacity expansion — Chintan Jain, Sagun Capital

Answered

Want to stabilize 6 GWh first, over next couple quarters look to go to 20 GWh. Axis partnership for Mahashakti product (not live yet, testing). 40% domestic value-add required by policy.

Guidance

Forward guidance and management's confidence

FY28: 400-500K units at 2-3 GWh cell consumption

Medium

Assumes 5 kWh average per vehicle (up from 3.8 kWh). Dependent on cell cost competitiveness proving out and dealer demand acceleration.

Gross margin: 30% now, decline Q3-Q4, then recover post-dealer stabilization

Medium

Down from prior 35-40% FY27 guidance. Dealer commissions drive Q3-Q4 decline; OM improvement promised but dependent on scale.

Operating margin: improve meaningfully from Q3 onwards as dealer ramp and cell contribution ramp

Low

Claims contradicted by Q2 EBITDA deterioration. OpEx still above ₹250-300 Cr quarterly target.

Capex 6→20 GWh: <₹400 Cr at full 20 GWh scale (vs ₹500+ Cr for 0→6)

Medium

Infrastructure already built for 20 GWh scale. Major capex cycle complete; tail-end payments and PLI-backed financing ongoing.

Risks the call surfaced

Ranked by how much they should concern a holder

Cell yield execution

High

Mid-70s NMC yields vs 90% target. Ramp timeline uncredible vs industry (Tesla 3 yrs, company claims couples months). Delays would crater margin benefits.

Margin recovery path

High

Gross margin 30% vs 35-40% FY27 guidance. Dealer commissions will depress further in Q3-Q4. OP margin recovery depends on cost discipline and cell contribution, both unproven.

Demand sustainability

High

Management claims 'demand ahead of supply', but revenue -39% YoY and backlog ₹500-1000 Cr (small). Dealer transition may cannibalize existing customer base; volume growth uncertain.

Profitability timeline

High

Operating EBITDA -₹246 Cr (Q2) vs -₹195 Cr (Q1), worsening. At current burn, profitability 18+ months away. Multiple levers must align (cell yield, dealer margin, OpEx ₹250-300 Cr achieved) simultaneously.

S1Z launch execution

Medium

Premium scooter S1Z launch pushed to Q4 with uncertain timeline ('might shift by month'). Only ₹500-1000 Cr reservations. Testing underway, approval pathway unclear.

Management

Score 6/10. Specific on cell yields and dealer store counts. Evasive on equity raised ('I don't have off top of my head'). Defensive on BoM gap and cell timeline comparisons without conceding industry benchmarks. Met cell commissioning milestone (6 GWh on 23 Sept). Dealer network scaled from 0 to 255 in ~2 months (real execution). But missed margin guidance (35-40% → 30%) and operating EBITDA deteriorated QoQ despite OpEx claims.

What to watch next
  • 1 · Q3-Q4 FY27

    Dealer transition margin stabilization and cell production ramp-up

  • 2 · Q3 FY27 (Jan 2027)

    PLI incentives expected to begin flowing; ₹1000 Cr GST refund accelerated under new 90% auto-approval rule

  • 3 · Q4 FY27 (Apr 2027)

    Gen 4 platform launch with LFP cells; S1Z premium product (testing underway, timeline uncertain)

Dealer transition and cell integration are real catalysts, but margin guidance was cut (35-40% → 30%), execution timelines are vague (cell yields, S1Z launch), and the company is 18+ months from operating profitability.

Informational and educational content only. Not investment advice.